Biogen Inc.

NasdaqGS:BIIB

Sector

🏥 Health Care

Industries

🧬 Biotechnology

🔬 Clinical Trials

💊 Pharmaceuticals

Location

United States

Market Cap

USD 18.77 B

Share Price

USD 128.00

Avg Daily Volume

1,488,264

Change (1 day)

-2.04%

Change (1 year)

-36.63%

Change (YTD)

-16.30%

Biogen Inc. EBITDA for the Trailing 12 Months (TTM) ending June 30, 2025: USD 2.79 B

Biogen Inc. EBITDA is USD 2.79 B for the Trailing 12 Months (TTM) ending June 30, 2025, a 24.24% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.

Biogen Inc. EBITDA for the Trailing 12 Months (TTM) ending June 30, 2024 was USD 2.25 B, a -26.83% change year over year.
Biogen Inc. EBITDA for the Trailing 12 Months (TTM) ending June 30, 2023 was USD 3.07 B, a 11.23% change year over year.
Biogen Inc. EBITDA for the Trailing 12 Months (TTM) ending June 30, 2022 was USD 2.76 B, a -17.07% change year over year.
Biogen Inc. EBITDA for the Trailing 12 Months (TTM) ending June 30, 2021 was USD 3.33 B, a -59.65% change year over year.